Candel Therapeutics, Inc.

Healthcare

NASDAQ:CADL · NASDAQ Global Market

Market Cap $469.95M Beta -0.48 P/E (TTM) -9.8

$8.56 +4.90%

+$0.40 today

52W Low $4.35High $9.57

Vol 1.36M · Avg 1.83M

EPS (TTM)-$0.87

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+66.86%

Period High

$9.27

Period Low

$4.42

Latest

$8.56

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Capricor Therapeutics, Inc.

NASDAQ:CAPR

$1.18B

Cabaletta Bio, Inc.

NASDAQ:CABA

$490.79M

Contineum Therapeutics, Inc. Class A Common Stock

NASDAQ:CTNM

$444.15M

Kyverna Therapeutics, Inc.

NASDAQ:KYTX

$352.74M

Editas Medicine, Inc.

NASDAQ:EDIT

$244.75M

ProQR Therapeutics N.V.

NASDAQ:PRQR

$151.72M

Genelux Corporation

NASDAQ:GNLX

$111.35M

Aldeyra Therapeutics, Inc.

NASDAQ:ALDX

$106.17M

Immutep Limited

NASDAQ:IMMP

$53.60M

Mereo BioPharma Group plc

MREO

$48.68M

What is the latest CADL filing?

The latest filing shown is SC 13G dated May 15, 2026.

How many recent filings does CADL have?

Intrinsic Alpha currently shows 20 recent filings for CADL.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.